Aprepitant and Aimovig drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aprepitant (aprepitant) and Aimovig (erenumab-aooe). Common drug interactions include abdominal pain upper among females.

The phase IV clinical study analyzes what interactions people have when they take Aprepitant and Aimovig. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

On Jul, 27, 2026

11 people who take Aprepitant and Aimovig together, and have interactions are studied.

Aprepitant and Aimovig drug interactions.

What are the common drug interactions of Aprepitant and Aimovig, by gender? *:

female:

Abdominal pain upper
Headache (pain in head)
Deep vein thrombosis postoperative (blood clot in a major vein that usually develops in the legs and/or pelvis after operation)
Delirium (wild excitement)
Depression
Diarrhoea
Dislocation of vertebra
Drug hypersensitivity
Drug ineffective
Duodenal ulcer perforation (untreated ulcer can burn through the wall of the stomach)

male:

n/a

What are the common drug interactions of Aprepitant and Aimovig, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain upper
Headache (pain in head)
Deep vein thrombosis postoperative (blood clot in a major vein that usually develops in the legs and/or pelvis after operation)
Delirium (wild excitement)
Depression
Diarrhoea
Dislocation of vertebra
Drug hypersensitivity
Drug ineffective
Duodenal ulcer perforation (untreated ulcer can burn through the wall of the stomach)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Stress And Anxiety: 6 people, 54.55%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 54.55%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 54.55%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 54.55%
Impaired Gastric Emptying: 3 people, 27.27%
Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 3 people, 27.27%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 9.09%
Synovitis (inflammation of the synovial membrane): 1 person, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and Aimovig?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously